Navigation Links
Data From QNEXA Sequel Study Featured at the 47th EASD Annual Meeting
Date:9/16/2011

MOUNTAIN VIEW, Calif., Sept. 16, 2011 /PRNewswire/ -- VIVUS, Inc. (NASDAQ: VVUS) today announced that multiple abstracts were presented at the 47th European Association for the Study of Diabetes (EASD) Annual Meeting in Lisbon, Portugal.  The presentations highlighted the long-term beneficial effects of QNEXA treatment in metabolically-impaired patients with prediabetes, diabetes, and metabolic syndrome.

The QNEXA presentations included:  

  • Decreased Progression to Diabetes in Subjects With Prediabetes After 2 Years of Treatment With Controlled-Release Phentermine/Topiramate, authored by W. Timothy Garvey, MD, et al.
  • Long-Term Weight Loss With Controlled-Release Phentermine/Topiramate Reverses Metabolic Syndrome and Improves Associated Traits, authored by Hermann Toplak, MD, et al.
  • Long-Term Glycaemic Effects of Weight Loss With Low-Dose, Controlled-Release Phentermine/Topiramate in Overweight/Obese Subjects with Diabetes, authored by Luc F. Van Gaal, MD, et al.

  • Highlights from the EASD presentations are as follows:

    A poster presentation authored by W. Timothy Garvey, MD from the University of Alabama at Birmingham reported that patients treated over two years with QNEXA had significant reductions in the progression to type 2 diabetes and improvement in glycemic status. Of the 675 patients in the two-year SEQUEL study, 316 were determined to have prediabetes at baseline. In the prediabetic sub-group treated with QNEXA, all glycemic parameters were significantly improved at week 108 (ITT-LOCF; P<0.05 vs. placebo). Progression to diabetes was reduced in the prediabetic sub-group with top-dose QNEXA vs. placebo (P=0.0125).  

    Luc Van Gaal, MD from the University of Antwerp in Belgium and Lawrence Cheskin, MD from Johns Hopkins University Weight Management Center authored a poste
    '/>"/>

    SOURCE VIVUS, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. VIVUS Provides Regulatory Update on QNEXA
    2. Obese Patients Treated With QNEXA Demonstrated Significant Improvement in Quality of Life
    3. Additional Data From QNEXA Clinical Trials Presented at the European Congress on Obesity
    4. Multiple Presentations Featuring QNEXA® Data to be Presented at the European Congress on Obesity
    5. QNEXA® Phase 3 Data in The Lancet Show Significant Weight Loss and Broad Improvements in Co-Morbidities
    6. Weight Loss With QNEXA® Over Two Years Provides Patients With Substantial Cardiovascular Benefits
    7. Long-Term Data on QNEXA® to be Presented at The American College of Cardiology Annual Meeting
    8. VIVUS Provides Regulatory Update on QNEXA NDA
    9. VIVUS Submits Briefing Document to FDA, Announces Follow-up Meeting to Discuss QNEXA®
    10. A Majority of Surveyed PCPs and Endocrinologists Indicate that they will Prescribe Contrave, Lorqess and Qnexa if these Therapies are Approved for Obesity
    11. FDA Issues Complete Response Letter to VIVUS Regarding New Drug Application for QNEXA®
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/26/2014)... China, Nov. 26, 2014 China Nepstar Chain ... "Company"), a leading retail drugstore chain in China based ... its unaudited financial results for the third quarter ended September ... 30, 2014: , Same store sales increased by ... , Revenue increased by 8.1% to RMB738.3 million (US$120.3 million) ...
    (Date:11/24/2014)...  Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) announced today ... and update at the Piper Jaffray 26 th Annual ... Eastern Time (5:30 a.m. Pacific Time), at The New York ... A live audio webcast of the presentation will be ... www.arenapharm.com . A replay of the presentation will be ...
    (Date:11/24/2014)... /PRNewswire/ - Milestone Pharmaceuticals, Inc. today announced data from a ... Melbourne, Australia of MSP-2017, a novel ... paroxysmal supraventricular tachycardia (PSVT).  The results demonstrated that ... at single doses up to and including 140 ... properties including rapid onset, and validating proof of ...
    Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 10China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 11Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 3Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 2Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 3
    ... Oct. 5, 2011 Reportlinker.com announces ... is available in its catalogue: ... Dermatological Drugs, 7th Edition ... This Kalorama Information report details the ...
    ... Calif., Oct. 5, 2011 In an independent study ... the University of Texas Health Science Center San Antonio ... to compromised blood flow during reconstructive microsurgery when compared ... study by Dr. Cornejo and colleagues is important as ...
    Cached Medicine Technology:The Market for Prescription Dermatological Drugs, 7th Edition 2The Market for Prescription Dermatological Drugs, 7th Edition 3The Market for Prescription Dermatological Drugs, 7th Edition 4The Market for Prescription Dermatological Drugs, 7th Edition 5The Market for Prescription Dermatological Drugs, 7th Edition 6The Market for Prescription Dermatological Drugs, 7th Edition 7The Market for Prescription Dermatological Drugs, 7th Edition 8The Market for Prescription Dermatological Drugs, 7th Edition 9The Market for Prescription Dermatological Drugs, 7th Edition 10The Market for Prescription Dermatological Drugs, 7th Edition 11The Market for Prescription Dermatological Drugs, 7th Edition 12The Market for Prescription Dermatological Drugs, 7th Edition 13The Market for Prescription Dermatological Drugs, 7th Edition 14The Market for Prescription Dermatological Drugs, 7th Edition 15Spectros T-Stat Shown to Be Earliest Available Method for Detection of Surgical Skin Flap Compromise After Surgery 2
    (Date:11/26/2014)... Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 ... on sales(at)researchmoz(dot)us , Researchmoz.us announces a new research ... with deep study of the report on the diabetes ... sugar. The global glucose monitoring market has a growth ... of diabetics in the world. Their numbers have prompted ...
    (Date:11/26/2014)... November 26, 2014 For those with a ... LES MILLS BODYPUMP™ classes at the University of ... workout they've been looking for. The 45- 60 minute classes ... Health and Wellness Center fitness club memberships. , LES MILLS ... are fast-paced and are aimed at fast results , ...
    (Date:11/26/2014)... (PRWEB) November 26, 2014 Sonoran ... ANP-BC, recently received the Distinguished Preceptorship Award from ... for her role in the advancement of nurse ... of an individual who had made a significant ... NPs. The American Association of Nurse Practitioners (AANP) ...
    (Date:11/26/2014)... News) -- Vultures have developed highly specialized ways of ... dead animals, researchers report. The new research investigated ... and in the guts of 50 turkey vultures and ... faces of the vultures had more than 500 different ... the study found. The findings suggest that a ...
    (Date:11/26/2014)... Nov. 25, 2014 (HealthDay News) -- Exposure to peanut ... peanut allergy in infants with the skin condition eczema, ... school-aged children in the United States are allergic to ... to food allergies, particularly peanut allergy, the researchers noted. ... months to 15 months. The researchers examined the amount ...
    Breaking Medicine News(10 mins):Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 3Health News:LES MILLS BODYPUMP™ classes come to the University of Colorado Anschutz Health and Wellness Center 2Health News:Sonoran Nurse Receives Distinguished Preceptorship Award from The American Association of Nurse Practitioners 2Health News:Infants With Eczema May Be More Prone to Peanut Allergy: Study 2
    ... ... Noni Fruit , ... (Vocus) May 19, 2010 -- Tahitian Noni International (TNI) has announced the creation ... company leaders have realized that noni is more than just a juice-and they are using ...
    ... ... Experience, View Their Photos, and Learn What Footwear To Pack for an African Safari , ... Seattle, Wash. (PRWEB) May 17, 2010 -- Good ... online shoe retailer before embarking on her honeymoon, vowing to pack only five pairs of shoes ...
    ... ... and young adults are ready for plastic surgery. , ... Voohees, NJ (Vocus) May 19, 2010 -- In light of recent media coverage of ... surgeon , Dr. Paul M. Parker, saw a great opportunity to address the right way to ...
    ... The neXante ... and xMM skin, respectively on Basal Cell Cancer, Squamous Cell Cancer, and Malignant Melanoma of ... only tracks and stores images of the skin, but also allows for recording the diagnosis, ... ...
    ... ... offers unique source of income for hard pressed primary care physicians. , ... Sacramento, CA (PRWEB) May 19, ... soon overwhelm private practice groups across the country with 31 million new patients. ...
    ... ... Angel Investors. , ... (PRWEB) May 19, 2010 -- SeniorHomes.com , an online directory and resource for ... it received a $1.1 million of Series A financing led by MentorTech Ventures of ...
    Cached Medicine News:Health News:New Bioactive Beverages Available From Tahitian Noni International 2Health News:The Bachelor's Molly Malaney Blogs About Honeymoon at Onlineshoes.com 2Health News:The Bachelor's Molly Malaney Blogs About Honeymoon at Onlineshoes.com 3Health News:With the Right Approach, Plastic Surgery for Teens and Young Adults is Now a Positive Experience 2Health News:With the Right Approach, Plastic Surgery for Teens and Young Adults is Now a Positive Experience 3Health News:With the Right Approach, Plastic Surgery for Teens and Young Adults is Now a Positive Experience 4Health News:With the Right Approach, Plastic Surgery for Teens and Young Adults is Now a Positive Experience 5Health News:neXante Turns Apple's iPhone Into Skin Cancer Surveillance Support Tool And Health Record 2Health News:Physicians Preferred Wellness Group Receives Prestigious MD Preferred Service Award 2Health News:SeniorHomes.com Closes $1.1 Million Series A Round of Investment Financing 2
    The Fathom Guidewire combines a nitinol hypotube distal segment with advanced microfabrication technology, creating a design that revolutionizes access of the most tortuous vasculature....
    ... for stent delivery. Uses perpendicular applied ... Allows user to adjust stent position ... tactile feel via fine adjustment and ... visualization at any angle. The Cordis ...
    Vial with 100 Urine Reagent Test Strips, tests for glucose, protein, pH, blood, ketone, bilirubin, nitrite, urobilinogen, specific gravity. FOR LABORATORY USE BY QUALIFIED TECHNICIANS....
    ... the latest from Quality Mapping Solutions, ... designed specifically for implementing and managing ... superior design, functionality, security, and versatility ... managing a quality program., ,Based upon ...
    Medicine Products: